Search Results - "Noseda, Roberta"

Refine Results
  1. 1

    Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database by Ceschi, Alessandro, Noseda, Roberta, Palin, Karine, Verhamme, Katia

    Published in Frontiers in pharmacology (04-05-2020)
    “…Immune checkpoint inhibitors (ICIs) have proven effective in the treatment of numerous cancers; however, they have been associated with immune-related adverse…”
    Get full text
    Journal Article
  2. 2

    Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports by Noseda, Roberta, Bertoli, Raffaela, Müller, Laura, Ceschi, Alessandro

    Published in Journal for immunotherapy of cancer (02-05-2019)
    “…Immune checkpoint inhibitor (ICI) use in clinical practice has unravelled a spectrum of immune-related adverse events (irAEs) due to immune system…”
    Get full text
    Journal Article
  3. 3

    Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data by Bonaldo, Giulia, Noseda, Roberta, Ceschi, Alessandro, Vaccheri, Alberto, Motola, Domenico

    Published in Scientific reports (12-08-2020)
    “…Rotaviruses (RVs) are the most common cause of severe diarrheal disease. To date two rotavirus oral vaccines are licensed: Rotarix and Rotateq. Our aim was to…”
    Get full text
    Journal Article
  4. 4

    Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase by Noseda, Roberta, Bedussi, Francesca, Gobbi, Claudio, Ceschi, Alessandro, Zecca, Chiara

    Published in Journal of headache and pain (19-01-2024)
    “…Background Current evidence on the safety of calcitonin gene–related peptide antagonists (CGRP-A) in pregnancy for the treatment of both episodic and chronic…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase by Noseda, Roberta, Ripellino, Paolo, Ghidossi, Sara, Bertoli, Raffaela, Ceschi, Alessandro

    Published in Vaccines (Basel) (14-09-2021)
    “…Since marketing authorization, cases of neuralgic amyotrophy (NA), facial paralysis/Bell’s palsy (FP/BP), and Guillain-Barré syndrome (GBS) were reported with…”
    Get full text
    Journal Article
  7. 7

    Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase by Noseda, Roberta, Bedussi, Francesca, Giunchi, Valentina, Fusaroli, Michele, Raschi, Emanuel, Ceschi, Alessandro

    Published in Journal for immunotherapy of cancer (03-11-2024)
    “…Background To date, evidence on late-onset immune-related adverse events (irAEs) with immune checkpoint inhibitors (ICIs) is limited to a small number of…”
    Get full text
    Journal Article
  8. 8

    Niacin‐mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination by Bolino, Alessandra, Piguet, Françoise, Alberizzi, Valeria, Pellegatta, Marta, Rivellini, Cristina, Guerrero‐Valero, Marta, Noseda, Roberta, Brombin, Chiara, Nonis, Alessandro, D'Adamo, Patrizia, Taveggia, Carla, Previtali, Stefano Carlo

    Published in EMBO molecular medicine (01-12-2016)
    “…Charcot–Marie–Tooth (CMT) neuropathies are highly heterogeneous disorders caused by mutations in more than 70 genes, with no available treatment. Thus, it is…”
    Get full text
    Journal Article
  9. 9

    DDIT4/REDD1/RTP801 is a novel negative regulator of Schwann cell myelination by Noseda, Roberta, Belin, Sophie, Piguet, Françoise, Vaccari, Ilaria, Scarlino, Stefania, Brambilla, Paola, Martinelli Boneschi, Filippo, Feltri, Maria Laura, Wrabetz, Lawrence, Quattrini, Angelo, Feinstein, Elena, Huganir, Richard L, Bolino, Alessandra

    Published in The Journal of neuroscience (18-09-2013)
    “…Signals that promote myelination must be tightly modulated to adjust myelin thickness to the axonal diameter. In the peripheral nervous system, axonal…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold by Noseda, Roberta, Guerrero-Valero, Marta, Alberizzi, Valeria, Previtali, Stefano C, Sherman, Diane L, Palmisano, Marilena, Huganir, Richard L, Nave, Klaus-Armin, Cuenda, Ana, Feltri, Maria Laura, Brophy, Peter J, Bolino, Alessandra

    Published in PLoS biology (12-04-2016)
    “…Microtubule-based kinesin motors have many cellular functions, including the transport of a variety of cargos. However, unconventional roles have recently…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Safety of Monoclonal Antibodies Inhibiting PCSK9 in Pregnancy: Disproportionality Analysis in VigiBase by Noseda, Roberta, Bedussi, Francesca, Panchaud, Alice, Ceschi, Alessandro

    Published in Clinical pharmacology and therapeutics (01-08-2024)
    “…Safety data on the use of monoclonal antibodies inhibiting proprotein convertase subtilisin/kexin type 9 in pregnancy are scarce. This study queried VigiBase®,…”
    Get full text
    Journal Article
  15. 15

    Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase by Noseda, Roberta, Bedussi, Francesca, Gobbi, Claudio, Ceschi, Alessandro, Zecca, Chiara

    Published in Cephalalgia (01-04-2023)
    “…Safety data on the use of migraine preventive monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) system in pregnancy are limited…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase by Noseda, Roberta, Bonaldo, Giulia, Motola, Domenico, Stathis, Anastasios, Ceschi, Alessandro

    Published in Cancers (06-03-2021)
    “…Older patients represent a subpopulation of concern for immune checkpoint inhibitor (ICI) toxicity because of changes in the aging immune system and the…”
    Get full text
    Journal Article
  19. 19
  20. 20